experiments were determined by measurement of change in dry weight of bacteria over this period. Mycobaterium tuberculosis var. bovis strain BCG was grown in a glutamate-glycerol medium (Winder & Collins, 1970) with shaking for about 10 days, 2pCi of [U-14C]glycerol of high specific activity was added to each flask, and each drug was added at its minimal inhibitory concentration to a group of flasks, other flasks serving as controls. After 6 h. the bacteria were harvested by filtration, rapidly washed with water, freeze-dried and an equal weight of each set of bacteria taken for fractionation. Free lipids were extracted, the bacteria were saponified, the saponified material was acidified, lipids (bound lipids) were extracted with ether and mycolic acids were precipitated from this extract with methanol. The free lipids, bound mycolic acids and bound lipids other than mycolic acid were dried, weighed and samples were taken for scintillation counting. The residue of material after saponification and extraction was also counted. Details of these procedures have been given by Winder & Collins (1970) .
Initial experiments of this type provided no evidence that either streptomycin or PAS had any appreciable effect on the synthesis of mycolic acids in the experimental period, as might be expected from what is known of the mechanism of action of these drugs onMycobacterium tuberculosis (Winder, I 964) . Consequently, the remaining three drugs were selected for further experiments (Table I) . These showed that Isoxyl and ethionamide quite markedly reduced the synthesis of mycolic acids, while providing no evidence for such an effect in the case of ethambutol.
In the case of Isoxyl, the inhibition of mycolic acid synthesis appeared to be only part of a more general inhibition, shown highly significantly in the case of the residue, with marginal significance in the case of the non-mycolic acid bound lipids, and suggested in the case of the free lipids (Table I ).
In the case of ethionamide, the inhibitory effect was largely restricted to the mycolic acid fraction, with a suggestion of an effect on the non-mycolic acid bound lipids. This pattern is like that shown by isoniazid (Winder & Collins, 1970) . In a number of other respects this drug affects Mycobacterium tuberculosis similarly to isoniazid (Rist, 1960; Schaefer, I 960 ;
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Short communication Winder & Rooney, I 970) . These facts suggest that ethionamide, like isoniazid, probably exerts its antibacterial action through inhibition of mycolic acid synthesis. There is no cross-resistance between the two drugs and hence their actions are not identical. For example, they might differ in the means by which they reach the sensitive site.
Thus it appears that three specific antituberculosis agents, isoniazid, ethionamide and Isoxyl, show a marked inhibitory effect on mycolic acid synthesis in BCG, though in the case of Isoxyl more widespread inhibitory effects are shown. No evidence for an effect on mycolic acid synthesis has emerged in the case of streptomycin, PAS or ethambutol. 
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